Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024

Rhea-AI Summary

Myomo, a wearable medical robotics company, will present at the Sidoti Virtual Investor Conference on June 12-13, 2024. The company’s chairman and CEO, Paul Gudonis, alongside CFO David Henry, will lead the presentation and host one-on-one meetings with investors. The presentation is scheduled for 10:00 a.m. ET on June 12th and is accessible online. Investors can also request one-on-one meetings on both days. Registration for the event is free and available on Sidoti’s website.

Positive

• Scheduled presentation at a reputable investor conference can increase visibility and attract potential investors.
• Opportunity to host one-on-one meetings with investors helps in building investor relations and possibly securing funding.

Negative

• No new product announcements or financial updates included in the press release.
• Potential investor expectations from the presentation might pressure the company's stock price if not met.

BOSTON--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024.

Management’s presentation will begin at 10:00 a.m. ET on Wednesday, June 12^th and can be accessed here. In addition, one-on-one meetings will be held with investors on both June 12^th and 13^th. To register to view the presentation or to request a one-on-one meeting with management, visit www.sidoti.com/events. Registration is free and open to all investors.

About Myomo, Inc.

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605096089/en/

For Myomo:

ir@myomo.com



Investor Relations:

Kim Sutton Golodetz

LHA Investor Relations

212-838-3777

kgolodetz@lhai.com

Source: Myomo, Inc.

FAQ

When will Myomo present at the Sidoti Virtual Investor Conference?

Myomo will present on June 12, 2024, at 10:00 a.m. ET.

What is the stock symbol for Myomo?

The stock symbol for Myomo is MYO.

Who will present for Myomo at the Sidoti Virtual Investor Conference?

Paul Gudonis, CEO, and David Henry, CFO, will present for Myomo.

How can I register to view Myomo's presentation at the Sidoti Virtual Investor Conference?

Registration is free and can be done through Sidoti’s website.

Will Myomo hold one-on-one meetings with investors during the Sidoti Virtual Investor Conference?

Yes, Myomo will hold one-on-one meetings with investors on June 12 and 13, 2024.